TREATMENT IMPLICATIONS OF THE REDUCE-IT RESULTS TO PEOPLE OF SOUTH ASIAN (SA) DESCENT LIVING IN CANADA WITH KNOWN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE(THE REDUCE-IT CANADA SA STUDY)
A. Krishnaraj(Toronto Public Health), Sumit Verma(Emory University), Jean‐François Tanguay(University of Ottawa), Andrew M. Demchuk(University of Calgary), G.B. John Mancini(Cedars-Sinai Medical Center), L.A. Leiter, P. Voisine(Toronto Public Health), P. Puar(Toronto Public Health), Hwee Teoh(St. Michael's Hospital), Bobby Yanagawa(St. Michael's Hospital), I. Firoz(Toronto Public Health), Ehab Bakbak(The University of Queensland), Bhavaani Lambotharan(Legacy International), A. Kirubaharan(Toronto Public Health), R. Kirubaharan(Toronto Public Health), Adrian Quan(St. Michael's Hospital), B. Bari(Toronto Public Health), Deepak L. Bhatt(Mount Sinai Hospital), J.C. Tardif(Toronto Public Health), R. Vijayaraghavan(Toronto Public Health)
Cited by 0
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k